QTI-seq Translation Initiation Profiling Service - Quantitative Mapping of Translation Start Sites

QTI-seq (quantitative translation initiation sequencing) is an initiation-focused ribosome profiling approach designed to map translation initiation sites (TISs) and compare their activity across biological conditions. Instead of treating all ribosome footprints as equivalent, QTI-seq enriches ribosomes positioned at initiation sites, making start-codon selection the primary experimental readout.

At CD Genomics, we coordinate study design, initiation-ribosome capture, ribosome-protected-fragment library construction, sequencing, initiation-specific quality control, and downstream TIS analysis. QTI-seq can also be integrated with Ribo-seq or RNA-seq when broader translational or transcript-abundance context is required.

Key Highlights:

  • Map annotated and alternative translation initiation sites at nucleotide-level resolution.
  • Compare start-site-specific initiation across biological conditions.
  • Investigate uTISs, dTISs, uORFs, and supported near-cognate non-AUG initiation.
  • Integrate QTI-seq with Ribo-seq or RNA-seq for multi-layer translational interpretation.
Submit Your Request Now
QTI-seq translation initiation profiling showing initiating ribosomes enriched at canonical and alternative start codons
Why QTI-seqComparisonWorkflowAnalysisApplicationsSamplesDeliverablesDemoCaseFAQ

Why Translation Initiation Needs a Dedicated Readout

Translation is often regulated before elongation begins. A transcript can use its annotated AUG, an upstream AUG, a downstream AUG, or a near-cognate non-AUG codon depending on cellular state. These choices can create uORFs, N-terminally extended or truncated protein isoforms, alternative coding frames, and condition-specific changes in protein output.

Conventional Ribo-seq (Ribosome Profiling) captures footprints from ribosomes distributed across translated regions. It is powerful for ribosome occupancy, three-nucleotide periodicity, translated ORF discovery, pausing, and codon-level behavior, but total footprint density is also shaped by elongation. QTI-seq changes the experimental question from where are translating ribosomes? to where are initiating ribosomes, and how strongly is each start site used?

The published QTI-seq strategy uses an initiation-selective inhibitor to preserve initiating ribosomes and puromycin to dissociate elongating ribosomes. This reduces run-off-related amplification that can complicate earlier initiation-mapping designs and supports quantitative comparisons of initiation-site occupancy between conditions.

What QTI-seq can resolve

For broader method selection across translation-omics, see our Translatomics Sequencing Services.

QTI-seq vs Other Translatomics Methods

FeatureQTI-seqConventional Ribo-seqTI/GTI-seq-style MappingPolysome Profiling
Primary questionWhere does translation initiate, and how does initiation change?Where are ribosomes engaged across translated regions?Where are initiation sites located?How strongly are transcripts loaded with ribosomes?
Primary signalInitiating-ribosome footprintsRibosome footprints across ORFsStart-site-enriched footprintsMonosome/polysome fraction distribution
ResolutionStart-site / nucleotide-levelCodon / nucleotide-levelStart-site / nucleotide-levelFraction / transcript-level
Quantitative initiation comparisonCore useIndirectMethod-dependentNo direct TIS readout
uTIS / dTIS / non-AUG analysisStrong fitPossible with appropriate analysisStrong fitNot direct
Elongation / pausing analysisNot the main purposeStrong fitNot the main purposeLimited

If the primary endpoint is active ribosome occupancy with a broader translatome readout, Enhanced Ribosome Profiling may be more appropriate. If the question is which RNA molecules are associated with active translation rather than where initiation occurs, RNC-seq addresses that different level of resolution.

QTI-seq Experimental and Service Workflow

QTI-seq depends on preserving the initiation state before downstream library construction, so experimental design and sample handling must be coordinated from the beginning.

Horizontal QTI-seq workflow from project design and initiating ribosome enrichment to sequencing and translation initiation site analysis

  1. Project design and contrast definition - Define biological groups, expected initiation mechanism, reference genome, and whether matched Ribo-seq or RNA-seq is needed.
  2. Sample collection strategy - Coordinate collection and handling before the experiment because initiation-state preservation depends on controlled inhibitor treatment and rapid processing.
  3. Initiating-ribosome enrichment - Preserve initiating ribosomes while depleting elongating ribosomes using the project-specific QTI-seq workflow.
  4. RPF isolation and library construction - Digest unprotected RNA, recover ribosome-protected fragments, and prepare sequencing libraries.
  5. Sequencing and initiation-specific QC - Evaluate fragment behavior, mapping, replicate concordance, and enrichment around annotated start sites.
  6. TIS calling and quantitative comparison - Identify candidate initiation sites, classify aTIS/uTIS/dTIS events, and test condition-dependent changes.
  7. Biological interpretation - Connect differential initiation to ORF architecture, gene function, and optional matched transcriptome/translatome layers.

Bioinformatics and Translation Initiation Analysis

Analysis ModuleTypical OutputResearch Value
Read preprocessing and alignmentFiltered reads, mapping statistics, genomic distributionEstablish data integrity before TIS inference
RPF length and positional QCFragment-length distribution and start-centered profilesConfirm support for initiation-site interpretation
Initiation-site enrichmentMetagene signal around annotated startsEvaluate selective capture of initiating ribosomes
TIS identificationCandidate aTIS, uTIS, dTIS, and alternative startsBuild a genome-wide initiation map
Start-codon classificationAUG and supported near-cognate categoriesCharacterize canonical and noncanonical initiation
Differential initiationSite-level effect sizes and significance statisticsIdentify initiation sites altered between conditions
uORF / alternative ORF annotationORF coordinates and relationship to the main CDSInterpret 5′-leader and alternative-start regulation
Functional interpretationGO/pathway summaries and prioritized gene setsConnect site-level changes to biological programs
Optional multi-layer integrationQTI-seq + Ribo-seq and/or RNA-seq comparisonSeparate initiation changes from total occupancy or RNA abundance

A useful escalation strategy is to add conventional Ribo-seq when both initiation-site occupancy and ribosome behavior across the coding region are required. RNA-seq becomes important when transcript abundance itself may change. These layers answer different parts of the same regulatory question rather than serving as interchangeable measurements.

Research Applications of QTI-seq

Alternative Start-Codon Selection

Map condition-specific use of annotated and alternative start sites when a gene is suspected to produce multiple protein isoforms.

uORF-Mediated Regulation

Identify initiating ribosomes in 5′ leaders and prioritize uORFs that may regulate downstream CDS translation.

Stress and Nutrient Response

Quantify initiation reprogramming when stress signaling or nutrient limitation is expected to alter start-site selection.

Alternative Proteoform Discovery

Use uTIS and dTIS evidence to prioritize N-terminal extensions, truncations, and alternative proteoforms for follow-up.

For noncoding-RNA-focused projects, our lncRNA Translation & Micropeptide Profiling service provides a complementary route for candidate coding events.

Sample Planning and Quality Controls

QTI-seq is highly dependent on how biological material is collected and treated. Because the assay uses inhibitor-based capture of initiating ribosomes, archived or conventionally frozen material should not be assumed compatible without review. We recommend discussing the sample workflow before collection.

Planning ItemQTI-seq Consideration
Biological materialCultured cells and experimentally tractable fresh tissues are the most direct starting points described in the published method literature
PreservationInitiation state must be preserved during collection and lysis; project-specific inhibitor handling is planned before submission
Comparative designMatched collection timing and processing should be used across experimental groups
ReplicatesBiological replication should be planned for differential initiation analysis; the exact number depends on biological variability and study design
Reference annotationA suitable genome/transcript annotation is required for confident TIS classification
Archived materialRequires feasibility review because post-collection inhibitor treatment may not reproduce intended initiation-state capture

If global ribosome loading rather than start-site mapping is the priority, Polysome Profiling + RNA-seq may be more appropriate.

Deliverables

Example QTI-seq Results

Representative QTI-seq outputs should make the initiation-specific signal visible rather than presenting only generic sequencing QC.

QTI-seq metagene plot showing enrichment of initiating ribosome footprints around translation start sitesFigure 1. Start-site enrichment profile
Start-centered metagene signal demonstrates whether the library is enriched for initiating ribosomes.

QTI-seq stacked bar chart classifying annotated upstream downstream and non-AUG translation initiation sitesFigure 2. Translation initiation site classes
aTIS, uTIS, dTIS, and alternative start categories summarize genome-wide start-site usage.

QTI-seq differential translation initiation volcano plot comparing start-site activity between experimental conditionsFigure 3. Differential initiation
Site-level comparison highlights initiation events whose occupancy changes across experimental groups.

Initiation enrichment

Verify that footprints concentrate around start sites rather than being distributed like standard Ribo-seq.

Alternative start usage

Summarize annotated and alternative initiation architecture across the transcriptome.

Condition-specific regulation

Prioritize start sites that change initiation independently of broad expression shifts.

Independent Published Example: Temporal QTI-seq Mapping

Kim and colleagues constructed a temporal atlas of transcriptome and translatome responses during SARS-CoV-2 infection in cultured cells. Their design included mRNA-seq, RPF-seq, QTI-seq, and small-RNA sequencing so transcript abundance, general ribosome occupancy, and translation initiation could be evaluated in parallel.

In Calu-3 cells infected at MOI 10, the authors collected early time points at 0, 1, 2, and 4 hours and later time points at 12, 16, 24, and 36 hours post infection. They also generated RPF-seq and QTI-seq datasets in additional cell-line and MOI settings.

Nature Communications Figure 1 experimental design for temporal QTI-seq RPF-seq and mRNA-seq profiling

Published Figure 1: Experimental design and generation of the temporal transcriptome-translatome datasets. Reproduced from the Nature Communications source article under CC BY 4.0 with attribution.

QTI-seq provided direct evidence for initiation-site usage across the viral genome. At 48 hours post infection in the additional MOI 0.1 experiments, the study reported that 11% of QTI-seq reads and 22% of RPF-seq reads mapped to a noncanonical CUG initiation site in the viral leader region. The authors further reported that more than 95% of reads associated with this leader initiation site mapped to subgenomic RNAs.

This independent study illustrates why QTI-seq can add information not provided by RNA-seq or general RPF-seq alone: initiation-site-specific footprints can reveal canonical and noncanonical start usage within a complex, changing translatome. It is presented as a published literature example, not a CD Genomics customer project or performance guarantee.

FAQs - QTI-seq Translation Initiation Profiling

    • What is the main difference between QTI-seq and standard Ribo-seq?
      • Standard Ribo-seq profiles ribosome-protected fragments across translated regions and is well suited to occupancy, periodicity, ORF translation, and elongation-related questions. QTI-seq enriches initiating ribosomes, making start-site identification and quantitative comparison of initiation events the primary readout.

    • Can QTI-seq detect non-AUG translation initiation?
      • Yes. Initiation-specific profiling can identify candidate near-cognate start sites in addition to annotated AUG starts. Interpretation should combine the footprint peak, sequence context, reproducibility, and ORF structure rather than treating every local signal as a validated protein product.

    • Is QTI-seq the same as GTI-seq?
      • No. Both belong to the translation-initiation-profiling family. The published QTI-seq workflow was developed to reduce biases associated with the run-off incubation used in earlier GTI-seq designs and to support quantitative comparison of initiation-site occupancy.

    • Do I need matched RNA-seq?
      • Not always. QTI-seq directly addresses initiation-site usage. Matched RNA-seq becomes useful when the study also needs to determine whether apparent initiation changes occur alongside changes in transcript abundance.

    • When should I add conventional Ribo-seq?
      • Add Ribo-seq when the project needs a full coding-region view of ribosome occupancy, elongation, pausing, periodicity, or global translation efficiency in addition to start-site-specific initiation. QTI-seq and Ribo-seq are complementary rather than redundant.

    • Can archived frozen tissue be used?
      • Feasibility must be reviewed case by case. QTI-seq depends on preserving initiating ribosomes through controlled inhibitor treatment and sample handling, so collection should ideally be planned before the experiment rather than assumed compatible after archiving.

References:

  1. Gao X, Wan J, Liu B, et al. Quantitative profiling of initiating ribosomes in vivo. Nature Methods. 2015;12:147-153.
  2. Zhang P, He D, Xu Y, et al. Genome-wide identification and differential analysis of translational initiation. Nature Communications. 2017;8:1749.
  3. Román ÁC, Benítez DA, Díaz-Pizarro A, et al. Next generation sequencing technologies to address aberrant mRNA translation in cancer. NAR Cancer. 2024;6(2):zcae024.
  4. Kim D, Kim S, Park J, et al. A high-resolution temporal atlas of the SARS-CoV-2 translatome and transcriptome. Nature Communications. 2021;12:5120.

For Research Use Only. Not for use in diagnostic or clinical procedures.



Inquiry
  • For research purposes only, not intended for clinical diagnosis, treatment, or individual health assessments.
Top